Leerink Partners Reiterates Outperform Rating on Fulcrum Therapeutics (FULC)

Go back to Leerink Partners Reiterates Outperform Rating on Fulcrum Therapeutics (FULC)
(NASDAQ: FULC) Delayed: 3.72 +0.03 (0.81%)
Previous Close $3.69    52 Week High
Open $3.70    52 Week Low
Day High $3.74    P/E N/A 
Day Low $3.62    EPS
Volume 901,397